Cytlimic Inc.

Nec Corporation

Shun Doi

Koji Tamada

Tomoya Miyakawa

The present invention provides a medicine comprising a Toll-like receptor agonist, LAG-3 protein, a variant or derivative thereof.

Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

The present invention provides a medicine containing a Toll-like receptor agonist, LAG-3 protein, a variant or derivative thereof.

Composition comprising poly I:C and LAG-3-IGG fusion protein

Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein

An information processing system, which supports a pathological diagnosis based on a tissue sample image which is obtained by imaging a body tissue, is provided, and the system includes: a pathological diagnosis unit () which performs a pathological diagnosis based on the tissue sample image and outputs a first pathological diagnosis result; an input unit () which inputs a second pathological diagnosis result obtained by a pathological diagnosis performed by a pathologist based on the tissue sample image; and an output unit () which outputs information necessary for a post process corresponding to combination of the first pathological diagnosis result and the second pathological diagnosis result.

Growing community of inventors

Tokyo, Japan

Shun Doi